Laurion Capital Management’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-35,792
| Closed | -$820K | – | 572 |
|
|
2024
Q1 | $820K | Hold |
35,792
| – | – | 0.01% | 221 |
|
|
2023
Q4 | $937K | Buy |
+35,792
| New | +$937K | 0.01% | 147 |
|
|
2023
Q2 | – | Sell |
-29,842
| Closed | -$561K | – | 462 |
|
|
2023
Q1 | $561K | Hold |
29,842
| – | – | ﹤0.01% | 153 |
|
|
2022
Q4 | $304K | Hold |
29,842
| – | – | ﹤0.01% | 170 |
|
|
2022
Q3 | $785K | Hold |
29,842
| – | – | ﹤0.01% | 172 |
|
|
2022
Q2 | $1.35M | Hold |
29,842
| – | – | 0.02% | 145 |
|
|
2022
Q1 | $2.94M | Hold |
29,842
| – | – | 0.04% | 90 |
|
|
2021
Q4 | $4.56M | Hold |
29,842
| – | – | 0.05% | 88 |
|
|
2021
Q3 | $4.05M | Hold |
29,842
| – | – | 0.02% | 157 |
|
|
2021
Q2 | $4.38M | Buy |
+29,842
| New | +$4.38M | 0.02% | 113 |
|